YTHDC1 inhibits osteoclast differentiation to alleviate osteoporosis by enhancing PTPN6 messenger RNA stability in an m6A-hUR–dependent manner
Journal of Leukocyte Biology · 29.05.2024 · 115 (6) · 1154-1164
DOI: 10.1093/jleuko/qiae021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, online erschienen am 30.01.2024. Verfasst von Meijie Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The Second Affiliated Hospital of Harbin Medical University, Nangang District, Harbin City, Heilongjiang Province, 150001, …. Hauptthemen laut MEDLINE: Cell Differentiation, Osteoclasts, Osteoporosis, RNA Stability. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Joint Guidance Project of Heilongjiang Provincial Natural Science Foundation.
Abstract (Originalsprache)
YTHDC1 has been confirmed to mediate osteoporosis (OP) progression by regulating osteogenic differentiation. However, whether YTHDC1 mediates osteoclast differentiation and its molecular mechanism remains unclear. Quantitative real-time polymerase chain reaction and Western blot analysis were performed to detect the levels of YTHDC1, PTPN6, NFATc1, TRAP, RUNX2, alkaline phosphatase, and HUR. YTHDC1 knockout mice was constructed by CRISPR/Cas9 system, and the OP mice model was established by ovariectomy. Hematoxylin and eosin staining and micro-computed tomography were used to evaluate bone formation and bone mass. Mouse primary bone marrow macrophage cells were isolated and induced into osteoclasts. TRAP-positive cells were detected using TRAP staining. MeRIP-qPCR, RIP-qPCR assay, RNA affinity isolation assay, and co-immunoprecipitation assay were used to confirm the interactions among YTHDC1, PTPN6, and HUR. YTHDC1 expression was reduced and positively correlated with lumbar bone mineral density in OP patients. In the ovariectomy model of YTHDC1 knockout mice, bone formation was reduced, bone histomorphology was changed, and osteoclastic-related factor (NFATc1 and TRAP) levels were enhanced. Overexpression YTHDC1 inhibited osteoclast differentiation. YTHDC1 increased PTPN6 messenger RNA stability in an m6A-dependent manner. Moreover, YTHDC1 interacted with HUR to positively regulate PTPN6 expression. PTPN6 knockdown promoted osteoclast differentiation, and this effect was reversed by overexpressing HUR or YTHDC1. YTHDC1 was involved in regulating OP progression through inhibiting osteoclast differentiation by enhancing PTPN6 messenger RNA stability in an m6A-HUR–dependent manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, The Second Affiliated Hospital of Harbin Medical University, Nangang District, Harbin City, Heilongjiang Province, 150001, P.R. China.
Förderung
- Joint Guidance Project of Heilongjiang Provincial Natural Science Foundation
Zitieren
APA
Zhang, M., Guan, J., Yu, S., Zhang, Y., Cheng, L., & Zhang, Y. (2024). YTHDC1 inhibits osteoclast differentiation to alleviate osteoporosis by enhancing PTPN6 messenger RNA stability in an m6A-hUR–dependent manner. Journal of Leukocyte Biology, 115(6), 1154-1164. https://doi.org/10.1093/jleuko/qiae021
Vancouver
Zhang M, Guan J, Yu S, Zhang Y, Cheng L, Zhang Y. YTHDC1 inhibits osteoclast differentiation to alleviate osteoporosis by enhancing PTPN6 messenger RNA stability in an m6A-hUR–dependent manner. Journal of Leukocyte Biology. 2024;115(6):1154-1164. doi:10.1093/jleuko/qiae021
BibTeX
@article{Zhang2024,
author = {Zhang, Meijie and Guan, Jiaxin and Yu, Simiao and Zhang, Yimeng and Cheng, Luyang and Zhang, Yina},
title = {YTHDC1 inhibits osteoclast differentiation to alleviate osteoporosis by enhancing PTPN6 messenger RNA stability in an m6A-hUR–dependent manner},
journal = {Journal of Leukocyte Biology},
year = {2024},
volume = {115},
number = {6},
pages = {1154--1164},
doi = {10.1093/jleuko/qiae021}
}
EUVIMED